The difference between Jintan in North China and Kangtai in Shenzhen

Jintan in North China and Kangtai in Shenzhen are both biopharmaceutical enterprises in China, which are different in business field, product research and development, market scope and so on.

1. Business field:

North China Jintan: North China Jintan is a biopharmaceutical enterprise specializing in vaccine research and development, production and sales. Its products mainly include influenza vaccine, rabies vaccine and Japanese encephalitis vaccine. In addition, the company is also engaged in the production of some blood products.

Shenzhen Kangtai: Shenzhen Kangtai is a comprehensive pharmaceutical enterprise integrating research and development, production and sales of biological products. Its business scope is wide, including vaccines, blood products, genetic engineering drugs and other fields. Kangtai's product line covers hepatitis B vaccine, influenza vaccine, rotavirus vaccine and hepatitis A vaccine.

2. Product development:

North China Jintan: North China Jintan focuses on vaccine research and development and production, especially in the field of influenza vaccine. The company has a number of R&D centers and production workshops, with strong R&D vaccine production capacity.

Shenzhen Kangtai: Shenzhen Kangtai has R&D investment in vaccines, blood products and genetic engineering drugs. Kangtai has several R&D platforms and production bases, and has strong drug R&D and production capacity. In addition, Kangtai also maintains close cooperation with scientific research institutions and medical institutions at home and abroad to jointly promote the development of the pharmaceutical industry.

3. Market scope:

North China Jintan: The market scope of North China Jintan is mainly in China. Although some products are exported, the main market is still at home.

Shenzhen Kangtai: The products of Shenzhen Kangtai not only cover the China market, but also are exported to many countries and regions. Kangtai has established a global sales network and gradually expanded its international market share.

Summary:

North China Jintan and Shenzhen Kangtai are both biopharmaceutical enterprises in China, but there are some differences in business areas, product development and market scope. North China Jintan focuses on vaccine research and development and production, especially in the field of influenza vaccine; Shenzhen Kangtai has a wider business scope, covering vaccines, blood products, genetic engineering drugs and other fields, and has a certain share in the international market.